Clover Corporation Limited Q4 2026 Earnings Recap

Clover’s shares rose 5.8% after FY26 revenue came in at AUD 97.4 million, slightly above the company’s AUD 92–96 million guidance range, alongside higher margins and profit. The result was supported by increased ARA demand and a richer product mix, though inventory growth absorbed cash and the company gave no specific forward guidance in the excerpt.

Key Takeaways

• Revenue rose 13% to AUD 97.4 million; gross margin increased 4 percentage points to 35.5%.
• EBITDA was AUD 17 million, up AUD 4.7 million year on year; NPAT rose 50% to AUD 10.5 million.
• Higher ARA powder demand, particularly from the infant formula market, and a more diversified product mix supported growth and margins.
• Net working capital increased AUD 7.5 million to AUD 49.8 million, driven by a AUD 19.8 million increase in inventory; management said this was to meet forecast demand and reflects long supply-chain lead times.
• Clover ended the year with AUD 7.2 million in cash and no interest-bearing liabilities; the board declared a final fully franked dividend of AUD 0.0125 per share.